A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment

American Journal of Drug and Alcohol Abuse

Volumn 25, Issue 2, 1999, Pages 207-218

  Hartz, Diane T ^a,d   Meek, Patricia ^a,b   Piotrowski, Nancy A ^a   Tusel, Donald J ^a,b   Henke, Curtis J ^c   Delucchi, Kevin ^a,b   Sees, Karen ^a,b   Hall, Sharon M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Technology Assessment Group   (United States)

^d UCSF Dept of Psychology (0984 TRC)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; REINFORCEMENT; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MENTAL HEALTH SERVICES; METABOLIC DETOXICATION, DRUG; METHADONE; NARCOTICS; NEGOTIATING; OPIOID-RELATED DISORDERS; REINFORCEMENT (PSYCHOLOGY); UNITED STATES;

EID: 0032950415     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-100101856     Document Type: Article

References (26)

1. French, M., Rachal, J., and Hubbard, R., Conceptual framework for estimating the social cost of drug abuse, J. Health Soc. Policy 2:1-22 (1991).
2. Rice, D., Kelman, S., and Miller, L., Economic costs of drug abuse, in Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, NIDA Research Monograph 113, U.S. Government Printing Office, Rockville, Maryland, 1991, pp. 10-32.
3. Yates, B., Cost-effectiveness analysis and cost-benefit analysis: An introduction, Behav. Assess. 7:207-234 (1985).
4. Harwood, H., Economics and drugs: Promises, problems, and prospects, in Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, NIDA Research Monograph 113, U.S. Government Printing Office, Rockville, Maryland, 1991, pp. 46-56.
5. Jerrell, J., Hu, T., and Ridgely, M., Cost-effectiveness of substance disorder interventions for people with severe mental illness, J. Ment. Health Adm. 21:283-297 (1994).
6. Center on Addictions and Substance Abuse at Columbia University, Substance Abuse and Urban America: Its Impact on an American City, New York, Center on Addictions and Substance Abuse at Columbia University, New York, 1996.
7. Harwood, H., Hubbard, R., Collins, J., et al., The costs of crime and the benefits of drug abuse treatment: A cost-benefit analysis using TOPS data, in Compulsory Treatment of Drug Abuse: Research and Clinical Practice, NIDA Research Monograph 86, U.S. Government Printing Office, Rockville, Maryland, 1988, pp. 209-235.
8. Hubbard, R., Marsden, M., Rachal, J., et al., Drug Abuse Treatment: A National Study of Effectiveness, The University of North Carolina Press, Chapel Hill, 1989.
9. Tabbush, V., The Effectiveness and Efficiency of Publicly Funded Drug Abuse Treatment and Prevention Programs in California: A Benefit-Cost Analysis, Economic Analysis Corporation, Los Angeles, 1986.
10. Yates, B., Toward the incorporation of costs, cost-effectiveness analysis, and cost-benefit analysis into clinical research, J. Consult. Clin. Psychol. 62:729-736 (1994).
11. French, M., Economic evaluation of drug abuse treatment programs: Methodology and findings, Am. J. Drug Alcohol Abuse, 21:111-135 (1995).
12. Bradley, C., French, M., and Rachal, J., Financing and cost of standard and enhanced methadone treatment, J. Substance Abuse Treat. 11:433-442 (1994).
13. McLellan, A., Kushner, H., Metzger, D., et al., The Fifth Edition of the Addiction Severity Index, J. Substance Abuse Treat. 9:199-213 (1992).
14. Hubbard, R., and French, M., New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment, in Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, NIDA Research Monograph 113, U.S. Government Printing Office, Rockville, Maryland, 1991, pp. 94-113.
15. Yates, B., Cost-effectiveness analysis, cost-benefit analysis, and beyond: Evolving models of the scientist/manager/practitioner, Clin. Psychol.: Sci. Pract. 2:385-398 (1995).
16. Apsler, R., Evaluating the cost-effectiveness of drug abuse treatment services, in Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, NIDA Research Monograph 113, U.S. Government Printing Office, Rockville, Maryland, 1991, pp. 57-66.
17. Hall, S. M., Clark, H. W., and Sees, K. L., Drug abuse, drug treatment, and public policy, in Drug Policy and Human Nature: Psychological Perspectives on the Control, Prevention and Treatment of Illicit Drug Use (W. K. Bickel and R. J. De Grandpre, Eds.), Plenum, New York, 1995.
18. Piotrowski, N. A., and Hall, S. M., Intensive psychosocial treatment with and without contingency management procedures in a methadone clinic, in Motivating Behavioral Change Among Illicit Drug Abusers: Contemporary Research on Contingency Management Interventions (S. T. Higgins and K. Silverman, Eds.), American Psychological Association Press, 1999, pp. 183-202.
19. Reilly, P., Banys, P., Tusel, D., et al., Methadone transition treatment: A model for 180-day methadone detoxification, Int. J. Addict. 30:387-402 (1995).
20. Higgins, S., Stitzer, M., Bigelow, G., et al., Contingent methadone delivery: Effects on illicit opiate use, Drug Alcohol Depend. 17:311-312 (1986).
21. Silverman, K., Higgins, S., Brooner, R., et al., Differential reinforcement of sustained cocaine abstinence in intravenous polydrug abusers, in Problems on Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting, NIDA Research Monograph 153, U.S. Government Printing Office, Rockville, Maryland, 1995, p. 212.
22. Ellison, J., Blum, N., and Barsky, A., Frequent repeaters in a psychiatric emergency service, Hosp. Community Psychiatry 40:958-960 (1989).
23. Purdie, F., Honigman, B., and Rosen, P., The chronic emergency department patient, Ann. Emerg. Med. 10:298-301 (1981).
24. Seage, G., Hertz, T., Stone, V., et al., The effects of intravenous drug use and gender on the cost of hospitalization for patients with AIDS, J. Acquir. Immune Defic. Syndr. 6:831-839 (1993).
25. Slaby, A., and Perry, P., Use and abuse of psychiatric emergency services, Int. J. Psychiatry Med. 10:1-8 (1980).
26. Sullivan, P., Bulik, C., Forman, S., et al., Characteristics of repeat users of a psychiatric emergency service, Hosp. Community Psychiatry 44:376-380 (1993).